These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16614631)

  • 1. Case files from the Bellevue Hospital Center at New York University--lipoatrophy following long-term antiretroviral therapy.
    Daskalakis D; Aberg JA
    MedGenMed; 2005 Oct; 7(4):9. PubMed ID: 16614631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
    Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthropometric definitions for antiretroviral-associated lipodystrophy derived from a longitudinal South African cohort with serial dual-energy X-ray absorptiometry measurements.
    Abrahams Z; Maartens G; Levitt N; Dave J
    Int J STD AIDS; 2018 Oct; 29(12):1194-1203. PubMed ID: 29945538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of HIV disease and antiretroviral therapy.
    Havlir DV; Currier JS
    Top HIV Med; 2006; 14(1):27-35. PubMed ID: 16641525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 6. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 7. Current perspectives on the management and prevention of antiretroviral-associated lipoatrophy.
    Phillips DR; Hay P
    J Antimicrob Chemother; 2008 Nov; 62(5):866-71. PubMed ID: 18703527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.
    Bhutia E; Hemal A; Yadav TP; Ramesh KL
    Afr Health Sci; 2014 Jun; 14(2):408-13. PubMed ID: 25320591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ART regimes and fat: the healing hand wielding the sword.
    Domingo P; Espinet J; Vidal F
    Lancet HIV; 2017 Jan; 4(1):e2-e3. PubMed ID: 27815067
    [No Abstract]   [Full Text] [Related]  

  • 10. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.
    Resino S; Micheloud D; Lorente R; Bellon JM; Navarro ML; Munoz-Fernandez MA
    HIV Med; 2011 Jan; 12(1):54-60. PubMed ID: 20497248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 13. [The side effects of antiretroviral therapy].
    Hartmann M
    Hautarzt; 2006 Nov; 57(11):969-74. PubMed ID: 17036249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the 11th conference on retroviruses and opportunistic infections.
    Laurence J
    AIDS Read; 2004 Apr; 14(4):151-3. PubMed ID: 15116693
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of facial lipoatrophy in HIV-infected patients.
    Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches to combating lipoatrophy: do they work?
    Martin A; Mallon PW
    J Antimicrob Chemother; 2005 May; 55(5):612-5. PubMed ID: 15761072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients.
    Doward LC; Dietz B; Wilburn J; McKenna SP; Bhor M; Rajagopalan R
    AIDS Read; 2008 May; 18(5):242-6, 252-6, 262-4. PubMed ID: 18589480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices.
    McComsey GA; O'Riordan M; Setzer B; Lebrecht D; Baron E; Walker UA
    Eur J Clin Nutr; 2008 Aug; 62(8):1031-7. PubMed ID: 17538545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics.
    Nolan D; Reiss P; Mallal S
    Expert Opin Drug Saf; 2005 Mar; 4(2):201-18. PubMed ID: 15794714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.
    Hartman K; Verweel G; de Groot R; Hartwig NG
    Pediatr Infect Dis J; 2006 May; 25(5):427-31. PubMed ID: 16645507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.